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RESUMO
Introdução: A doença arterial obstrutiva periférica tem um importante impacto a nível de morbi/mortalidade. O objetivo deste trabalho 
é quantificar o impacto desta doença em Portugal, ao longo dos últimos oito anos, expresso pelo volume de internamento, tratamento 
e pela morbi-mortalidade respetiva. 
Material e Métodos: Foram analisados os registos de internamento no Serviço Nacional de Saúde entre 2009 e 2016 da base 
de dados dos grupos de diagnósticos homogéneos utilizando os códigos 9th revision of the International Statistical Classification of 
Diseases and Related Health Problems (ICD-9) de diagnóstico e procedimentos. Verificámos o número de casos em cada ano por 
estadio de doença, dados demográficos, fatores de risco, tratamento e morbi-mortalidade.
Resultados: No período de estudo a doença arterial periférica conduziu a 27 684 internamentos o que correspondeu a cerca de 
26,7 % do total de internamentos por patologia vascular neste período. Cerca de 49,9 % dos doentes foram admitidos em contexto 
de urgência. Os procedimentos em doentes claudicantes diminuíram ao longo dos oito anos ao contrário dos doentes com isquémia 
crítica em que os procedimentos aumentaram. 
Discussão: A idade e a presença de fatores de risco cardiovasculares têm sido associadas à gravidade da doença, tal como na nossa 
série. A mortalidade hospitalar global varia, sendo mais significativa nos doentes com doença mais avançada. 
Conclusão: A doença arterial periférica é uma patologia com importante representação no internamento dos hospitais do Serviço 
Nacional de Saúde. Há ainda um importante volume de doentes admitidos no contexto de urgência o que sugere eventual falta de 
reconhecimento/referenciação atempada por parte dos cuidados saúde primários, devendo mais esforços ser realizados no sentido de 
aumentar a interação entre os cuidados de saúde primários e os hospitais terciários.
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ABSTRACT
Introduction: Peripheral arterial disease has an important impact on morbidity/mortality. The objective of this study was to quantify 
the impact of this disease in Portugal during the last eight years, expressed by the volume of admissions, treatment strategies and 
associated morbidity and mortality.
Material and Methods: We collected data from the Diagnosis Related Group national database on primary diagnosis, procedures 
codes, demographic variables, a number of risk factors, and mortality of all cases admitted from 2009 to 2016 with a primary diagnosis 
of peripheral arterial disease coded according to the 9th revision of the International Statistical Classification of Diseases and Related 
Health Problems (ICD-9).
Results: In this study, peripheral arterial disease led to 27 684 hospitalisations, which corresponded to 26.7% of all admissions 
for vascular disease in this period. Approximately 49.9% of patients were admitted to the emergency department. The volume of 
procedures in patients with claudication decreased over the eight years, unlike patients with critical ischaemia, in which the number of 
procedures increased. 
Discussion: Age and the presence of cardiovascular risk factors have been associated with the severity of disease, as observed in our 
series. Overall hospital mortality varied, being significantly higher in patients with more advanced severity of the disease.  
Conclusion: Peripheral arterial disease represents an important burden in the overall volume of admissions in Portuguese public 
hospitals. A large number of patients was admitted in the context of emergency. 
Keywords: Arterial Occlusive Diseases/epidemiology; Peripheral Vascular Diseases/epidemiology
INTRODUCTION
 The increase in life expectancy and aging of the popula-
tion, combined with the lifestyle adopted by most popula-
tions, has changed the global epidemiology of atherosclero-
sis and arterial disease.
 It has been estimated that about 202 million people live 
with peripheral arterial disease (PAD), meaning a very sig-
nificant disease burden considering their direct and indirect 
contribution to global morbidity and mortality.1
 In a study conducted in the United States of America 
(USA), based on data from the National Health and Nutri-
tion Examination Survey between 1999 and 2000, the prev-
alence of PAD was about 4.3%; this figure was higher in 
men, and increased dramatically with age (0.9% in subjects 
under 50 years of age and 14.5% in individuals aged 70 
years or over).2,3
 In Portugal, and according to a study undertaken by 
A
R
TI
G
O
 O
R
IG
IN
A
L
Revista Científica da Ordem dos Médicos          www.actamedicaportuguesa.com                                                                                                                349
Moutinho M, et al. Global impact of peripheral obstructive arterial disease in Portugal: an eight year study, Acta Med Port 2019 May;32(5):348-354
the Portuguese Society of Angiology and Vascular Surgery 
(SPACV) in 2008, which included 5731 individuals in Main-
land Portugal (average age 67 years), 132 in Madeira and 
122 in Azores, the prevalence of PAD in the Continent was 
5.9%, being approximately 2 times higher in males (8.4% vs 
4.1%).4
 It is expected that the prevalence of PAD increases with 
the aging of the population, the persistence of smoking5 and 
the increase of risk factors such as diabetes mellitus, obe-
sity and hypertension.3
 In asymptomatic patients, 26% develop critical limb is-
chaemia one year after diagnosis. In patients with critical is-
chaemia, with no revascularisation standard, approximately 
40% lose lower limb integrity within six months and more 
than 20% die.6
 Regarding the natural history, in a recent meta-analy-
sis,7 most patients with intermittent claudication presented 
an increased 5-year cumulative cardiovascular-related mor-
bidity, with a level of 13% vs 5% in the reference population. 
Regarding the limb risk, 21% of patients progress to chronic 
limb-threatening ischaemia at 5 years, of whom 4% – 27% 
undergo amputations.6
 Some studies also suggest that PAD, even in asympto-
matic patients, is associated with a level of morbidity and 
mortality that is comparable to coronary and cerebrovascu-
lar disease and possibly at a higher cost.8 Patients with an 
ankle brachial index (ABI) < 0.9, regardless of whether or 
not they present with symptoms, have a level of morbidity 
and mortality that is higher than individuals of the same age 
group with normal ABI.9,10,11 According to Fowkes et al, indi-
viduals with a diagnosis of PAD with or without symptoms 
of lower limb ischaemia have an approximately three times 
higher risk of mortality and major cardiovascular events 
[acute myocardial infarction (AMI) and stroke] compared to 
individuals without PAD.9 Between 45 and 202 million peo-
ple with PAD die of coronary or cerebrovascular disease 
within a 10-year period, with the risk of amputation ranging 
from 1% – 3% in five years and may reach 90% in patients 
with critical ischaemia.1
 The economic impact of this condition has been evalu-
ated in several countries, particularly in the USA, and anal-
yses of data from the Reduction of Atherothrombosis for 
Continued Health Registry assessed the total hospitalisa-
tion costs related to arterial pathology at around 21 billion 
dollars, with most of the costs being associated with revas-
cularisation procedures.12
 The purpose of this study was to characterise the impact 
of peripheral arterial disease on the National Health Service 
(NHS) in Portugal over the last eight years, quantifying hos-
pitalisation, treatment, morbidity and mortality.
MATERIAL AND METHODS
 This investigation is part of a project entitled “Vascular 
Surgery in Portugal: Knowing to Improve”, a partnership be-
tween the National School of Public Health, NOVA Univer-
sity, and the Faculty of Medicine of the University of Lisbon, 
which was supported by Fundação Calouste Gulbenkian.
 Data were obtained from the Diagnosis Related Group 
(DRG) national database which contains data from all ad-
missions to Portuguese public hospitals (mainland Portu-
gal). We collected data on primary diagnosis, procedures 
codes, demographic variables (such as sex and age), a 
number of risk factors, and mortality rate. All cases admitted 
between 2009 and 2016 with a primary diagnosis of PAD 
coded in 9th revision of the International Statistical Classifi-
cation of Diseases and Related Health Problems (ICD-9) as 
indicated in Table 1 (diagnosis) were analysed.
 The number of cases in each year was recorded along 
with demographic data (sex, age), disease stage, risk fac-
tors, treatment, hospital morbidity and mortality, as well as 
the evolution of hospitalisation levels for PAD throughout 
these eight years. We compared the type of admission, the 
number of hospitalised patients, the duration of hospital ad-
mission, the mortality rate and the percentage of patients 
discharged from hospital according to the various stages of 
the disease.
 After identifying the population with PAD involving the 
lower limbs, the diagnostic codes were cross-referenced 
with the codes of the most commonly performed procedures 
in this condition, with the aim of finding a pattern or trend in 
the treatment of these patients during the aforementioned 
time period.
Statistical analysis
 The comparison between groups for continuous vari-
ables was performed using analysis of variance (ANOVA), 
with an adjustment for multiple comparisons through the 
Bonferroni test. T-student test was applied if the categori-
cal variable presented only two categories. Trend analyses 
were performed using simple linear regression. Compari-
sons between categorical variables were made using the 
chi-square test. The analyses were performed using SPSS 
version 22 and considering p < 0.05 as the threshold for 
significance.
RESULTS
 Although the number of hospitalisations due to vascular 
disease (obstructive carotid disease, deep venous thrombo-
sis, chronic venous insufficiency, acute lower limb ischemia, 
peripheral arterial disease, abdominal and peripheral artery 
aneurysms, and vascular trauma) decreased over a period 
of six years (19 267 in 2009 to 14 381 in 2014), hospitalisa-
tion levels for PAD remained relatively stable, with a ten-
dency to increase from 4102 in 2009 to 4428 in 2015, with a 
slight decrease in 2016 to 3893.
 During the period of our study, the diagnosis of PAD led 
to 27 684 hospitalisations, which corresponded to about 
0.6% of all admissions in adults and 26.7% of all hospitali-
sations due to vascular disease  (obstructive carotid dis-
ease, deep venous thrombosis, chronic venous insufficien-
cy, acute lower limb ischemia, peripheral arterial disease, 
abdominal and peripheral artery aneurysms, and vascular 
trauma). About 26 825 hospitalisations were the result of 
atherosclerotic disease of the lower limbs (corresponding 
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to 96.8% of the PAD) and of these, 238 corresponded to 
hospitalisations due to a recurrence of disease (i.e. patients 
previously subjected to procedures listed in Table 1 for pe-
ripheral arterial disease.).
 Patients were grouped into five age groups: 18 to 24 
years old, 25 to 44, 45 to 64, 65 to 84, and older than 85 
years old; 42.3% were aged between 65 and 84 years and 
more than half of the patients were male (69.5%).
 The most frequent comorbidities were arterial hyperten-
sion (HT) (13 228) and diabetes mellitus (DM) (9902) fol-
lowed by dyslipidaemia (6302) and ischaemic heart disease 
(4360).
 Regarding the type of admission, approximately 49.9% 
of patients hospitalised for PAD involving the lower limbs 
were admitted to hospital after presenting to an emergency 
department.
 Patients with PAD were classified according to the ICD 9 
classification by categories according to the following symp-
toms: claudication, rest pain, ischaemic leg ulceration and 
gangrene. In general, there appears to be a trend reflected 
by the reduction in hospitalisations at earlier stages (i.e. 
less severe, especially patients with claudication), as op-
posed to patients with more advanced stages, such as rest 
pain, leg ulcer and gangrene (Fig. 1).
 For patients with claudication, the number of hospitali-
sations decreased from 811 to 363 between 2009 and 2016; 
this decrease was significant (p = 0.01).
 The number of patients hospitalised for rest pain and 
leg ulcer increased from 505 to 595 (p = 0.015) and from 
619 to 880 (p < 0.001), respectively, from 2009 to 2016. The 
number of patients hospitalised for gangrene totalled 1824 
in 2009 and reached a peak of 2206 cases in 2010. From 
2010 to 2016, this number decreased slightly to around 
2055, but was not statistically significant (Fig. 1).
 Patients with intermittent claudication belonged to 
younger groups, with 51.2% being aged 45 - 64 years; on 
the contrary, in the groups with critical ischaemia, the pre-
dominant age group was older, with the majority being aged 
between 65 and 84 years. There is an increasing proportion 
of patients over 85 years of age as the disease stage pro-
gresses (9.1%, 14.4% and 23.9% in patients with rest pain, 
leg ulcer and gangrene, respectively). Also, the period of 
hospitalisation and hospital mortality varied in a direct ratio 
with severity of the disease, with the number of days of hos-
pitalisation being 5.43, 9.2, 16.4 and 17.4 and mortality of 
0.8%, 3.0%, 5.6% and 13.5%, respectively, in patients with 
claudication, rest pain, ulcer and gangrene; the difference 
was statistically significant (p < 0.001). On the contrary, 
the percentage of patients who were discharged home de-
creased according to the severity of the disease: 95.8, 89.5, 
86.3 and 78.3 in patients with claudication, rest pain, ulcer 
or gangrene, respectively (Table 2). Despite this trend, the 
Table 1 – ICD-9 codes used in this paper
Diagnosis/Procedures Code
Diagnosis
  Atherosclerosis of the aorta 440.0
  Atherosclerosis of the native extremities 440.2
     Intermittent claudication 440.21
     Resting pain 440.22
     Ulcer 440.23
     Gangrene 440.24
  Chronic total occlusion of the arteries of the extremities 440.4
  Atherosclerosis of extremities bypass 440.3
Procedures
  Open Surgery
  Aorto-iliac-femoral bypass 39.25
  Other peripheral vascular bypass 39.29
  Endarterectomy of the lower limbs 38.18
  Vessel repair with autologous patch 39.56
  Vessel repair with synthetic patch 39.57
  Vessel repair with non-specific patch 39.58
Endovascular Procedure
  Insertion of stent in peripheral vessel 39.90
  Non-coronary vessel angioplasty 39.50
  Insertion of stent with drug in peripheral vessel 00.55
Review of lower limb vascular surgery
  Control haemorrhage after vascular surgery 39.41
  Another review of vascular procedure 39.49
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overall mortality by PAD did not change over the eight-year 
period (Fig. 2).
 Also, patients with more advanced disease (rest pain 
and/or ulceration and gangrene) had higher rates of admis-
sion in the emergency department compared to those with 
claudication: 85% vs 15% (Table 2).
 Diagnostic codes were cross-referenced with the codes 
of the most commonly performed treatment procedures. 
In the patients hospitalised for PAD involving the lower limbs 
(code 440.2), 12 166 procedures were performed: 5925 
(48.7%) were open/conventional surgery, 5895 (48.5%) 
were endovascular procedures and 346 (2.8%) were revi-
sions of previous surgeries. Regarding open surgery, the 
number of procedures remained relatively constant over the 
eight year period, with an average of 800 procedures per 
year; there was a statistically significant tendency for the 
Figure 2 – DAP hospital admission (blue column) and mortality (red line) per year from 2009 to 2016 
Total DAP hospital admission
Mortality due to DAP
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340
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325
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Figure 1 – Total number of patients hospitalised for PAD according to stage of disease between 2009 and 2016
Intermitent claudication
Resting pain
Ulcer
Gangrene
2009
811
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619
1824
2010
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628
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784
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2139
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893
2037
2015
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749
982
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2016
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2055
Table 2 – Predominant age group, duration of hospitalisation, mortality, home discharge and type of admission due to stage of disease
Stages Claudication   Rest pain Ulcer Gangrene p
Age Group Predominant 45 – 64 65 – 84 65 – 84 65 – 84
Type of Urgent Admission
(%)
4847
(15%)
5308
(16%)
6383
(19%)
16 712 
(50%)
< 0.001
Days of hospitalization
(mean)
5.43 9.2 16.4 17.4 < 0.001
Mortality
(%)
39
(0.8%)
158 
(3.0%)
359 
(5.6%)
2255 
(13.5%)
< 0.001
Home Discharge
(%)
4644
(95.8%)
4731
(89.5%)
5456
(86.3%)
12 977
(78.3%)
< 0.001
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number of procedures to decrease from 822 to 766 in the 
period from 2013 and 2016. This reality is also true for hos-
pitalisations in patients with a recurrence of disease, with 
values remaining stable throughout the studied period (av-
erage of 44 procedures per year). In contrast, endovascular 
treatment increased from 900 to 1609 from 2013 to 2015, 
with a rapid decrease in 2016 (Fig. 3).
 The percentage of procedures performed in patients 
with claudication was 23%, was 23.7% in hospitalised pa-
tients with rest pain, 21.2% in patients with leg ulcers and 
32% in patients with gangrene. The difference between in-
terventions performed in patients with claudication versus 
more advanced stages (resting pain + active ulcer + gan-
grene) was highly significant (p < 0.001) regardless of the 
type of treatment (open versus endovascular surgery).
 In general, the number of procedures in patients with 
claudication decreased over the eight year period (from 455 
to 323 in 2009 and 2016, respectively), unlike patients with 
critical ischaemia, in which the number of procedures in-
creased in the eight year period [either openly (from 487 
to 633 in 2009 and 2016), and patients undergoing endo-
vascular procedures (from 326 to 735 in 2009 and 2016, 
respectively)]. 
 Patients subjected to endovascular procedures had re-
duced lengths of stay in hospitals as well as reduced in-hos-
pital mortality, as shown in Table 3; this difference was sta-
tistically significant (the p-values obtained are unadjusted).
DISCUSSION
 PAD is a common manifestation of systemic atheroscle-
rotic disease and, when present, it is a valuable indicator 
of severity, the involvement of other areas such as the cer-
ebrovascular and coronary regions and also a marker of 
higher morbidity and mortality. PAD is also  associated with 
a 5-fold increased short-term risk of AMI or stroke, and a 
3-fold increase in the risk of death when compared to indi-
viduals in the same age range without PAD.2,13
 Age and the presence of cardiovascular risk factors have 
been associated with the severity of disease and the same 
trend was also observed in our series, where more than 
40% of patients were between 65 and 84 years and most 
had hypertension, diabetes mellitus and/or dyslipidaemia.14 
Moreover, in our sample, more advanced clinical stages of 
PAD were present in older age groups, and frequently as-
sociated with more advanced systemic atherosclerotic dis-
ease, increased severity of their clinical manifestations and 
higher surgical risk, thus representing a greater burden of 
disease for hospital admissions within the NHS. According 
to Abu Dabrh et al, in a meta-analysis, there is a high rate of 
mortality and limb loss associated with critical limb ischemia 
(almost one in five patients during a median follow-up of 
one year) with wounds or ulcers more likely to worsen.15
 Health promotion, with the modification of risk factors 
and adequate lifestyle, as well as personal and social hab-
its, are particularly important for the prevention of PAD in 
Figure 3 – Number of procedures performed during these eight years (open surgery: blue line; endovascular procedures: red line; re-
interventions: grey line)
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Table 3 – Comparing open procedure with endovascular procedure considering number of days of hospitalisation and mortality 
Open Surgery Endovascular Procedure p Both
Days of hospitalisation 20.07 12.95 < 0.001 21.43
Mortality (%) 5.6 3.02 < 0.001 8.62
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order to reduce the burden of disease and its effect upon 
the use of resources within the NHS. Implementation and 
adherence to programs promoting healthy lifestyles, such 
as a balanced diet, smoking cessation and regular exercise, 
will be necessary to change the present reality of PAD in the 
Portuguese health service. The introduction of supervised 
exercise programs, as suggested by Mazari et al,16 where 
comparisons were performed in patients with claudication 
between those treated with endovascular revascularisation 
versus a conservative approach (supervised exercise pro-
tocol) was conducted. Reduction in the cost per quality-ad-
justed life year (QALY) gain was lower: €6167 for exercise 
versus €11 777 for endovascular treatment, confirming su-
pervised exercise as a cost-effective approach in the initial 
management of these patients.16,17,18
 Annual hospital mortality rate for patients with asympto-
matic PAD varies from 5% to 7%, with this value being high-
er than the mortality due to coronary disease or stroke.19 
The five-year mortality rate of patients with critical ischae-
mia ranged from 10% to 15% (75% were of cardiovascular 
origin), with the remaining 20% developing a non-fatal car-
diovascular event.20 In our series, overall hospital mortality 
also varied, between 6% and 8%, being significantly higher 
in patients with more advanced severity of the disease.
 Several studies suggest that PAD is still an under-di-
agnosed and under-treated disease because it is often 
asymptomatic. In a study conducted in Canada by Morge 
et al, important gaps in knowledge and public awareness 
in the general population concerning PAD were identified in 
elder individuals with lower education levels.21
 Another relevant issue in our series was the fact that 
69% of the patients with gangrene (a more advanced stage 
of the disease) were admitted in an emergency setting, sug-
gesting either late referral of these patients for observation 
and treatment in specialised vascular services or difficulty 
accessing those services. This represents an important is-
sue and confirms a perception from our data of inadequate 
responses to the patients’ need for adequate and timely 
recognition of the disease leading to the late treatment of 
patients with PAD.
 Decisions concerning conventional open or endovas-
cular revascularisation procedures for PAD treatment were 
beyond the scope of the present study. However, our data 
confirmed an increase in endovascular procedures over the 
eight year period and a reduction in the in-hospital mortal-
ity when compared with open conventional revascularisa-
tion. Despite this increase in endovascular treatment, the 
rates of open surgery and endovascular surgery were simi-
lar during the study period (48.7% open surgery vs 48.5% 
endovascular treatment). The number of hospitalisations for 
recurrent arterial disease has tended to increase in the last 
year, although not significantly. This may be due to the in-
creased use of endovascular techniques which have been 
associated with a greater number of re-interventions com-
pared to open surgery.
 In fact, our data confirm that PAD represents an impor-
tant burden on public health care resources and associated 
evidence from other studies confirms the high prevalence 
of diabetes in the Portuguese population,22 it is therefore 
reasonable to expect that PAD will continue to represent 
a major burden upon public health resources in the future. 
Despite the limitations of our study, which is based on ad-
ministrative data and not on clinical records, thus reducing 
the possibility of a more rigorous evaluation of the impact 
of smoking and other risk factors, separate analyses of 
the adequacy of each intervention for each individual case 
and a lack of information on long-term outcomes, our study 
provides information on the impact of PAD in hospital ad-
missions in Portuguese public hospitals, on the evolution 
of treatment strategies within an eight year period and its 
impact on in-hospital mortality and duration of hospitalisa-
tion. The economic and clinical burden of cardiovascular 
disease in general and PAD in particular could not be as-
sessed in our study; however, according to the published 
literature, they will present a major public health problem 
and a huge challenge for health systems in the near future. 
Greater and better clinic-based computer records should be 
implemented in order to obtain adequate information and 
to provide a more complete and thorough evaluation of the 
true impact of the disease in our country, the adequacy of 
the treatment strategies and its mid- and long-term efficacy. 
Therefore additional efforts are needed to increase commu-
nication between Primary Health Care Units and Hospitals.
CONCLUSION
 Aging of the population and the increased prevalence of 
some risk factors suggest a continued high prevalence of 
PAD and an increased need for resources to provide timely 
and effective treatment for these patients. It was clear from 
our data that efforts should be made to improve the pre-
vention of PAD and risk factor modification, as well as to 
promote the early referral of these patients to specialised 
treatment. Further efforts should be made to educate the 
population to increase the awareness of PAD and improve 
early diagnosis, as well as prompt referral to treatment in 
specialised vascular facilities, as major requirements to re-
duce the relevant clinical and economic impact on hospitali-
sation in NHS hospitals in Portugal.
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